Astera Labs (ALAB) reported robust Q3 2025 results, with revenue soaring 103.9% YoY to $230.6M and EPS of $0.49 beating consensus, yet the stock closed 2.20% lower amid significant insider selling and valuation concerns.
- The company raised its Q4 EPS guidance to $0.50–$0.51 and projected revenue between $245M and $253M.
- The unexpected decline was driven by a sharp 49.54% drop in trading volume and $89.33M in insider selling.
- Valuation concerns (P/E of 155.51) and competition from Broadcom and Marvell tempered the positive results, despite an average analyst target of $188.17.